Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ADIR's new MMP and TNF-alpha production inhibitors described in recent patent

Jan. 31, 2000

Access to begin phase II trial of OraRinse for treatment and prevention of mucositis

Jan. 31, 2000

NYU School of Medicine and P&U establish anticancer drug discovery collaboration

Jan. 31, 2000

Oxford BioMedica and IDM to collaborate on cell-based therapies

Jan. 31, 2000

Two new anticancer human MAbs enter development at AVI BioPharma

Jan. 28, 2000

Schering-Plough seeks E.U. approval of Caelyx for treatment of advanced ovarian cancer

Jan. 28, 2000

Licensing opportunity from NIH: 5-lipoxygenase inhibitors as anticancer agents

Jan. 28, 2000

Novel CDK4 inhibitor series available for licensing from NIH

Jan. 27, 2000

Dendreon initiates patient enrollment in phase III prostate cancer study

Jan. 27, 2000

Eisai team identifies promising new selective RARalpha agonist

Jan. 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...